See the DrugPatentWatch profile for Prozac
Information on Prozac's 2023 sales is not publicly available. Drug sales data for specific products in a given year is typically released by pharmaceutical companies in their annual financial reports, which are usually published in the first few months of the following year.
When might Prozac's 2023 sales be reported?
Companies like Eli Lilly and Company, which manufactures Prozac, often disclose sales figures as part of their quarterly and annual earnings calls. These reports are usually made public within a few months after the close of the fiscal year. Therefore, information regarding 2023 sales would likely become available in early to mid-2024 [1].
What has Prozac's past sales performance been?
Prozac (fluoxetine) has been a widely prescribed antidepressant for decades. While specific annual sales figures fluctuate, the drug has historically generated significant revenue for Eli Lilly. Global sales for Prozac and its related products have been substantial, though detailed historical sales data for Prozac alone would require specific financial report analysis [1].
How does patent expiry affect Prozac sales?
Prozac's primary patents have long expired, leading to the availability of generic versions. The market entry of generics typically causes a significant decline in the sales of the brand-name drug as prices become more competitive. Eli Lilly's sales data would reflect this shift from brand-name sales to overall market performance including generics [2]. Information on patent expiry dates for key drugs can be found on DrugPatentWatch.com [3].
What are the key competitors to Prozac?
Prozac belongs to the class of drugs known as selective serotonin reuptake inhibitors (SSRIs). It competes with a range of other SSRIs, such as Zoloft (sertraline), Paxil (paroxetine), and Celexa (citalopram), as well as other classes of antidepressants like serotonin-norepinephrine reuptake inhibitors (SNRIs) and atypical antidepressants. The availability of numerous generic antidepressants also impacts the market share of individual brand-name drugs [4].
What is Prozac prescribed for?
Prozac is primarily prescribed to treat major depressive disorder. It is also used for conditions including obsessive-compulsive disorder (OCD), bulimia nervosa, panic disorder, and premenstrual dysphoric disorder (PMDD) [5].
What are common side effects of Prozac?
Common side effects associated with Prozac can include nausea, insomnia, drowsiness, nervousness, and changes in appetite. Patients are advised to consult with their healthcare provider regarding potential side effects and their management [5].
Sources:
[1] Eli Lilly and Company Investor Relations. (n.d.).
[2] Generic Competition and Brand Drug Sales. (n.d.).
[3] DrugPatentWatch.com. (n.d.).
[4] Antidepressant Medications. (n.d.).
[5] Prozac (fluoxetine hydrochloride) Prescribing Information. (n.d.).